Clinical study of ursodeoxycholic acid to evaluate the efficacy and safety of ursodeoxycholic acid for the prevention of common bile duct stones following successful removal.

Not Applicable

• Conditions: Common bile duct stones

• Registration Number: JPRN-UMIN000020774
• Lead Sponsor: Department of General Internal Medicine, Hiroshima University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-31
• Study Completion: 2022-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 420

Inclusion Criteria

Not provided

Exclusion Criteria

1.A history of gastrectomy. 2.Current treatment for cancer. 3.Complete obstruction of the biliary tract. 4.Current treatment for fulminant hepatitis. Women who were pregnant or breast-feeding, had signs of pregnancy, or were planning to become pregnant. 5.Alcohol abuse. 6.A history of hypersensitivity to the study drug. 7.Current treatment with another bile acid formulation (e.g., Urso or Chino capsule), cholagogue (e.g., dehydrocholic acid, Supacal, Felviten, and Inchinkoto) , bile acid adsorbent (cholestimide or Questran), or agents under development. 8.Patients who were judged to be ineligible for the study by the investigator for other reasons.

Study & Design

• Study Type: Interventional
• Study Design: Not specified